Narrative review / 2023
Incorporating a plant-based diet was reported to improve remission and relapse outcomes in Crohn's disease and ulcerative colitis.
The authors review dietary factors in inflammatory bowel disease and describe outcomes incorporating a lacto-ovo-semi-vegetarian plant-based diet (PBD) into inpatient and post-discharge practice. First-line therapy with infliximab and PBD achieved a remission rate of 96% (44/46) in Crohn's disease (CD) and 76% (13/17) in severe ulcerative colitis (UC). In CD, a relapse-free outcome was achieved in 52% of patients at 10-year follow-up without biologics or immunosuppressants, while cumulative relapse rates for 51 initial episode UC cases at 1 and 5 years were 14% and 27%, respectively. Additionally, PBD alone induced remission without medication in approximately one-third of mild UC cases.
- Study type
- Narrative review with clinical case series data
- Who was studied
- Patients with Crohn's disease and ulcerative colitis
- What was measured
- Remission and relapse rates in Crohn's disease and ulcerative colitis
THE PAPER
Therapeutic advancement in inflammatory bowel disease by incorporating plant-based diet.
Chiba M, Tsuji T, Komatsu M. Transl Gastroenterol Hepatol, 2023.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.